Literature DB >> 11725037

Mechanisms of Tax Regulation of Human T Cell Leukemia Virus Type I Gene Expression.

A.A. Franklin1, J.K. Nyborg.   

Abstract

During the last several years, the human T cell leukemia virus type I (HTLV-I) has become recognized as an important cause for public health concern throughout the world. HTLV-I is the causative agent of a variety of clinical diseases, including an aggressive lymphoproliferative disorder named adult T cell leukemia. HTLV-I induces pathogenicity in the infected host cell through the synthesis of a virally encoded protein called Tax. Expression of Tax is critical to the life cycle of the virus, as the protein greatly increases the efficiency of HTLV-I gene transcription and replication. Furthermore, Tax has been shown to deregulate the transcription of many cellular genes, leading to the hypothesis that the presence of Tax promotes unchecked growth in the HTLV-I-infected cell. The mechanism of Tax trans-activation of HTLV-I gene expression is not known. Tax does not bind directly to the Tax-responsive promoter elements of the virus, but appears to function through interaction with certain cellular DNA binding proteins, including activating transcription factor 2 and cAMP response element binding protein that recognize these sequences. This review summarizes some of the recent work in the field aimed at elucidating the mechanism of Tax trans-activation of HTLV-I gene expression. Copyright 1995 S. Karger AG, Basel

Entities:  

Year:  1995        PMID: 11725037     DOI: 10.1007/bf02257921

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  24 in total

1.  Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation.

Authors:  H A Giebler; J E Loring; K van Orden; M A Colgin; J E Garrus; K W Escudero; A Brauweiler; J K Nyborg
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter.

Authors:  Kasey L Konesky; Jennifer K Nyborg; Paul J Laybourn
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Transcriptional activation of RNA polymerase III-dependent genes by the human T-cell leukemia virus type 1 tax protein.

Authors:  J M Gottesfeld; D L Johnson; J K Nyborg
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb.

Authors:  C Neuveut; K G Low; F Maldarelli; I Schmitt; F Majone; R Grassmann; K T Jeang
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

5.  In vitro transcription of human T-cell leukemia virus type 1 is RNA polymerase II dependent.

Authors:  B A Lenzmeier; J K Nyborg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax.

Authors:  I Lemasson; V Robert-Hebmann; S Hamaia; M Duc Dodon; L Gazzolo; C Devaux
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y.

Authors:  C A Pise-Masison; J Dittmer; K E Clemens; J N Brady
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

8.  Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles.

Authors:  O J Semmes; K T Jeang
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  HTLV-I Tax self-association in optimal trans-activation function.

Authors:  D Y Jin; K T Jeang
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

10.  Expression status of Tax protein in human T-cell leukemia virus type 1-transformed MT4 cells: recall of MT4 cells distributed by the NIH AIDS Research and Reference Reagent Program.

Authors:  K T Jeang; D Derse; M Matocha; O Sharma
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.